Publications

Publications from OUS - Section for Breast and Endocrine Surgery

109 publications found

Publications 2019

  1. Bonsaksen T, Heir T, Ekeberg Ø, Grimholt TK, Lerdal A, Skogstad L, Schou-Bredal I (2019)
    Self-evaluated anxiety in the Norwegian population: prevalence and associated factors
    Arch Public Health, 77, 10
    DOI 10.1186/s13690-019-0338-0, PubMed 30923612
  2. Faye-Schjøll HH, Schou-Bredal I (2019)
    Pessimism predicts anxiety and depression in breast cancer survivors: A 5-year follow-up study
    Psychooncology, 28 (6), 1314-1320
    DOI 10.1002/pon.5084, PubMed 30950120
  3. Grimholt TK, Bonsaksen T, Schou-Bredal I, Heir T, Lerdal A, Skogstad L, Ekeberg Ø (2019)
    Flight Anxiety Reported from 1986 to 2015
    Aerosp Med Hum Perform, 90 (4), 384-388
    DOI 10.3357/AMHP.5125.2019, PubMed 30922426
  4. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF (2019)
    Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry
    Int J Med Inform, 125, 102-109
    DOI 10.1016/j.ijmedinf.2019.03.004, PubMed 30914174
  5. Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF et al. (2019)
    Breast cancer quantitative proteome and proteogenomic landscape
    Nat Commun, 10 (1), 1600
    DOI 10.1038/s41467-019-09018-y, PubMed 30962452
  6. Schou-Bredal I, Bonsaksen T, Heir T, Skogstad L, Lerdal A, Grimholt T, Ekeberg O (2019)
    Optimists report fewer physical and mental health conditions than pessimists in the general Norwegian population
    HEALTH PSYCHOL. REP., 7 (1), 9-18

Publications 2018

  1. Bonsaksen T, Grimholt TK, Skogstad L, Lerdal A, Ekeberg Ø, Heir T, Schou-Bredal I (2018)
    Self-diagnosed depression in the Norwegian general population - associations with neuroticism, extraversion, optimism, and general self-efficacy
    BMC Public Health, 18 (1), 1076
    DOI 10.1186/s12889-018-5990-8, PubMed 30157827
  2. Bonsaksen T, Lerdal A, Heir T, Ekeberg Ø, Skogstad L, Grimholt TK, Schou-Bredal I (2018)
    General self-efficacy in the Norwegian population: Differences and similarities between sociodemographic groups
    Scand J Public Health, 1403494818756701 (in press)
    DOI 10.1177/1403494818756701, PubMed 29417880
  3. Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, Bjerve KS, Hjartåker A (2018)
    Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment
    Nutr J, 17 (1), 94
    DOI 10.1186/s12937-018-0402-6, PubMed 30333016
  4. Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V (2018)
    Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
    Genome Med, 10 (1), 92
    DOI 10.1186/s13073-018-0601-y, PubMed 30497530
  5. Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
    Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
    Br J Cancer, 119 (9), 1144-1154
    DOI 10.1038/s41416-018-0211-x, PubMed 30401977
  6. Moberg IO, Schou Bredal I, Schneider MR, Tønseth KA, Schlichting E (2018)
    Complications, risk factors, and patients-reported outcomes after skin-sparing mastectomy followed by breast reconstruction in women with BRCA mutations
    J Plast Surg Hand Surg, 52 (4), 234-239
    DOI 10.1080/2000656X.2018.1470093, PubMed 29741462
  7. Norum J, Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Undlien DE, Schlichting E, Mæhle L (2018)
    BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
    ESMO Open, 3 (3), e000328
    DOI 10.1136/esmoopen-2018-000328, PubMed 29682331
  8. Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T (2018)
    Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
    Eur Thyroid J, 8 (1), 31-40
    DOI 10.1159/000493977, PubMed 30800639
  9. Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
    Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
    J Thromb Haemost, 16 (7), 1347-1356
    DOI 10.1111/jth.14151, PubMed 29766637

Publications 2017

  1. Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E et al. (2017)
    Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
    Breast Cancer Res, 19 (1), 44
    DOI 10.1186/s13058-017-0812-y, PubMed 28356166
  2. Bjørklund SS, Panda A, Kumar S, Seiler M, Robinson D, Gheeya J, Yao M, Alnæs GIG, Toppmeyer D, Riis M, Naume B, Børresen-Dale AL, Kristensen VN, Ganesan S, Bhanot G (2017)
    Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
    Sci Rep, 7 (1), 5568
    DOI 10.1038/s41598-017-05537-0, PubMed 28717182
  3. Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M (2017)
    Interactions between the tumor and the blood systemic response of breast cancer patients
    PLoS Comput Biol, 13 (9), e1005680
    DOI 10.1371/journal.pcbi.1005680, PubMed 28957325
  4. Fleischer T, Klajic J, Aure MR, Louhimo R, Pladsen AV, Ottestad L, Touleimat N, Laakso M, Halvorsen AR, Grenaker Alnæs GI, Riis ML, Helland Å, Hautaniemi S, Lønning PE, Naume B, Børresen-Dale AL, Tost J, Kristensen VN (2017)
    DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
    Oncotarget, 8 (1), 1074-1082
    DOI 10.18632/oncotarget.13718, PubMed 27911866
  5. Fleischer T, Tekpli X, Mathelier A, Wang S, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E, Oslo Breast Cancer Research Consortium (OSBREAC), Børresen-Dale AL, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN (2017)
    DNA methylation at enhancers identifies distinct breast cancer lineages
    Nat Commun, 8 (1), 1379
    DOI 10.1038/s41467-017-00510-x, PubMed 29123100
  6. Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Mæhle L, Undlien DE, Norum J, Schlichting E (2017)
    Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
    BMC Cancer, 17 (1), 438
    DOI 10.1186/s12885-017-3422-2, PubMed 28637432
  7. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2017)
    Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
    World J Surg Oncol, 15 (1), 118
    DOI 10.1186/s12957-017-1184-6, PubMed 28673296
  8. Hetmann F, Kongsgaard UE, Sandvik L, Schou-Bredal I (2017)
    Post-thoracotomy pain syndrome and sensory disturbances following thoracotomy at 6- and 12-month follow-ups
    J Pain Res, 10, 663-668
    DOI 10.2147/JPR.S126639, PubMed 28356766
  9. Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, Kremeyer B, Luo L, von Holst S, Kontham V, Thutkawkorapin J, Margolin S, Du Q, Lundin J, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN et al. (2017)
    PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1
    Oncotarget, 8 (61), 102769-102782
    DOI 10.18632/oncotarget.21800, PubMed 29262523
  10. Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, Kyte JA, Kristensen VN, Geitvik GA, Schlichting E, Wist EA, Sørlie T, Russnes HG, Naume B (2017)
    Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
    Breast Cancer Res, 19 (1), 120
    DOI 10.1186/s13058-017-0911-9, PubMed 29137653
  11. Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL et al. (2017)
    The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
    Clin Cancer Res, 23 (16), 4662-4670
    DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444
  12. Vaysse C, Lomo J, Garred O, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husoy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer (vol 3, 35, 2017)
    npj Breast Cancer, 3, UNSP 35
  13. Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
    NPJ Breast Cancer, 3, 35
    DOI 10.1038/s41523-017-0030-x, PubMed 28884144
  14. Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
    NPJ Breast Cancer, 3, 19
    DOI 10.1038/s41523-017-0015-9, PubMed 28649659

Publications 2016

  1. Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016)
    Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
    Lipids Health Dis, 15, 56
    DOI 10.1186/s12944-016-0225-4, PubMed 26970778
  2. Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, Anton-Culver H, Arndt V, Baynes C, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brenner H, Broeks A, Burwinkel B, Chang-Claude J, NBCS Collaborators, Couch FJ et al. (2016)
    Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
    Oncotarget, 7 (49), 80140-80163
    DOI 10.18632/oncotarget.12818, PubMed 27792995
  3. Haukaas TH, Euceda LR, Giskeødegård GF, Lamichhane S, Krohn M, Jernström S, Aure MR, Lingjærde OC, Schlichting E, Garred Ø, Due EU, Mills GB, Sahlberg KK, Børresen-Dale AL, Bathen TF, Oslo Breast Cancer Consortium (OSBREAC) (2016)
    Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes
    Cancer Metab, 4, 12
    DOI 10.1186/s40170-016-0152-x, PubMed 27350877
  4. Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PDP, Dunning AM, Shah M, Luben R, Bojesen SE, Nordestgaard BG, Schoemaker M, Swerdlow A, García-Closas M, Figueroa J, Dörk T, Bogdanova NV, Hall P, Li J, Khusnutdinova E, Bermisheva M, Kristensen V, Borresen-Dale AL et al. (2016)
    Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
    Genet Med, 19 (5), 599-603
    DOI 10.1038/gim.2016.147, PubMed 27711073
  5. Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T (2016)
    A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma
    Thyroid, 26 (9), 1225-38
    DOI 10.1089/thy.2015.0673, PubMed 27400880

Publications 2015

  1. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2015)
    Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008
    Ann Surg Oncol, 22 (12), 3836-45
    DOI 10.1245/s10434-015-4441-3, PubMed 25743325
  2. Hetmann F, Kongsgaard UE, Sandvik L, Schou-Bredal I (2015)
    Prevalence and predictors of persistent post-surgical pain 12 months after thoracotomy
    Acta Anaesthesiol Scand, 59 (6), 740-8
    DOI 10.1111/aas.12532, PubMed 25907109
  3. Kåresen R, Lunde C (2015)
    [Not Available]
    Tidsskr Nor Laegeforen, 135 (23-24), 2148-50
    DOI 10.4045/tidsskr.15.1176, PubMed 26674034
  4. Silwal-Pandit L, Russnes H, Borgen E, Skarpeteig V, Moen Vollan HK, Schlichting E, Kåresen R, Naume B, Børresen-Dale AL, Farnebo M, Langerød A (2015)
    The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
    PLoS One, 10 (10), e0139965
    DOI 10.1371/journal.pone.0139965, PubMed 26460974
  5. Tinholt M, Vollan HK, Sahlberg KK, Jernström S, Kaveh F, Lingjærde OC, Kåresen R, Sauer T, Kristensen V, Børresen-Dale AL, Sandset PM, Iversen N (2015)
    Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
    Breast Cancer Res, 17, 44
    DOI 10.1186/s13058-015-0548-5, PubMed 25882602

Publications 2014

  1. Dumeaux V, Ursini-Siegel J, Flatberg A, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Lund E (2014)
    Peripheral blood cells inform on the presence of breast cancer: a population-based case-control study
    Int J Cancer, 136 (3), 656-67
    DOI 10.1002/ijc.29030, PubMed 24931809
  2. Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis ML, Haakensen VD, Wärnberg F, Naume B, Helland A, Børresen-Dale AL, Tost J, Christensen BC, Kristensen VN (2014)
    Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
    Genome Biol, 15 (8), 435
    DOI 10.1186/PREACCEPT-2333349012841587, PubMed 25146004
  3. Frydenberg H, Flote VG, Iversen A, Finstad SE, Furberg AS, Torjesen PA, Wilsgaard T, Schlichting E, Ellison PT, Ursin G, Thune I (2014)
    Insulin-like growth factor-1, growth hormone, and daily cycling estrogen are associated with mammographic density in premenopausal women
    Cancer Causes Control, 25 (7), 891-903
    DOI 10.1007/s10552-014-0389-z, PubMed 24801047
  4. Glubb DM, Maranian MJ, Michailidou K, Pooley KA, Meyer KB, Kar S, Carlebur S, O'Reilly M, Betts JA, Hillman KM, Kaufmann S, Beesley J, Canisius S, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Schmidt MK, Broeks A, Hogervorst FB, van der Schoot CE, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P et al. (2014)
    Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1
    Am J Hum Genet, 96 (1), 5-20
    DOI 10.1016/j.ajhg.2014.11.009, PubMed 25529635
  5. Reiche K, Kasack K, Schreiber S, Lüders T, Due EU, Naume B, Riis M, Kristensen VN, Horn F, Børresen-Dale AL, Hackermüller J, Baumbusch LO (2014)
    Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes
    PLoS One, 9 (9), e106076
    DOI 10.1371/journal.pone.0106076, PubMed 25264628
  6. Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA (2014)
    Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures
    Arch Phys Med Rehabil, 95 (5), 875-81
    DOI 10.1016/j.apmr.2013.12.015, PubMed 24389401
  7. Schou Bredal I, Kåresen R, Smeby NA, Espe R, Sørensen EM, Amundsen M, Aas H, Ekeberg Ø (2014)
    Effects of a psychoeducational versus a support group intervention in patients with early-stage breast cancer: results of a randomized controlled trial
    Cancer Nurs, 37 (3), 198-207
    DOI 10.1097/NCC.0b013e31829879a3, PubMed 23782517
  8. Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E (2014)
    Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain
    J Pain Symptom Manage, 48 (5), 852-62
    DOI 10.1016/j.jpainsymman.2013.12.239, PubMed 24703940
  9. Steindal SA, Bredal IS, Ranhoff AH, Sørbye LW, Lerdal A (2014)
    The last three days of life: a comparison of pain management in the young old and the oldest old hospitalised patients using the Resident Assessment Instrument for Palliative Care
    Int J Older People Nurs, 10 (4), 263-72
    DOI 10.1111/opn.12076, PubMed 25418556
  10. Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
    Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
    BMC Cancer, 14, 845
    DOI 10.1186/1471-2407-14-845, PubMed 25407022

Publications 2013

  1. Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B (2013)
    Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma -- a retrospective comparison of 32 patients
    Acta Oncol, 52 (8), 1771-7
    DOI 10.3109/0284186X.2013.765065, PubMed 23398621
  2. Hagen AI, Mæhle L, Vedå N, Vetti HH, Stormorken A, Ludvigsen T, Guntvedt B, Isern AE, Schlichting E, Kleppe G, Bofin A, Gullestad HP, Møller P (2013)
    Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers
    Breast, 23 (1), 38-43
    DOI 10.1016/j.breast.2013.10.002, PubMed 24210736
  3. Hannisdal E, Arianson H, Braut GS, Schlichting E, Vinnem JE (2013)
    A risk analysis of cancer care in Norway: the top 16 patient safety hazards
    Jt Comm J Qual Patient Saf, 39 (11), 511-6
    PubMed 24294679
  4. Hetmann F, Schou-Bredal I, Sandvik L, Kongsgaard UE (2013)
    Does chronic pre-operative pain predict severe post-operative pain after thoracotomy? A prospective longitudinal study
    Acta Anaesthesiol Scand, 57 (8), 1065-72
    DOI 10.1111/aas.12159, PubMed 23859248
  5. Hofvind S, Schlichting E, Ursin G, Sebuødegård S, Kåresen R (2013)
    [Breast cancer surgery in Norway 1986-2009]
    Tidsskr Nor Laegeforen, 133 (15), 1582-6
    DOI 10.4045/tidsskr.12.0840, PubMed 23970271
  6. Hovind IL, Bredal IS, Dihle A (2013)
    Women's experience of acute and chronic pain following breast cancer surgery
    J Clin Nurs, 22 (7-8), 1044-52
    DOI 10.1111/jocn.12167, PubMed 23480500
  7. Synnestvedt M, Borgen E, Schlichting E, Schirmer CB, Renolen A, Giercksky KE, Nesland JM, Naume B (2013)
    Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome
    Breast Cancer Res Treat, 138 (2), 485-97
    DOI 10.1007/s10549-013-2439-8, PubMed 23456230

Publications 2012

  1. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
    Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
    Histol Histopathol, 27 (10), 1315-25
    DOI 10.14670/HH-27.1315, PubMed 22936450
  2. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
    Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
    Histopathology, 61 (3), 350-64
    DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749
  3. Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC (2012)
    Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
    Eur Heart J, 34 (12), 886-893c
    DOI 10.1093/eurheartj/ehs262, PubMed 22942338
  4. Sahlberg KK, Hongisto V, Edgren H, Mäkelä R, Hellström K, Due EU, Moen Vollan HK, Sahlberg N, Wolf M, Børresen-Dale AL, Perälä M, Kallioniemi O (2012)
    The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells
    Mol Oncol, 7 (3), 392-401
    DOI 10.1016/j.molonc.2012.10.012, PubMed 23253899
  5. Schou Bredal I, Kåresen R, Skaane P, Engelstad KS, Ekeberg Ø (2012)
    Recall mammography and psychological distress
    Eur J Cancer, 49 (4), 805-11
    DOI 10.1016/j.ejca.2012.09.001, PubMed 23021930
  6. Steindal SA, Ranhoff AH, Bredal IS, Sørbye LW, Lerdal A (2012)
    Last three days of life in the hospital: a comparison of symptoms, signs and treatments in the young old and the oldest old patients using the Resident assessment instrument for palliative care
    Int J Older People Nurs, 8 (3), 199-206
    DOI 10.1111/j.1748-3743.2012.00313.x, PubMed 22329702
  7. Synnestvedt M, Borgen E, Russnes HG, Kumar NT, Schlichting E, Giercksky KE, Kåresen R, Nesland JM, Naume B (2012)
    Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
    Acta Oncol, 52 (1), 91-101
    DOI 10.3109/0284186X.2012.713508, PubMed 22934555

Publications 2011

  1. Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (2011)
    Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
    Mol Oncol, 5 (6), 564-76
    DOI 10.1016/j.molonc.2011.08.004, PubMed 21917534
  2. Chrisanthar R, Knappskog S, Løkkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjønsberg G, Aas T, Schlichting E, Fjösne HE, Nysted A, Lillehaug JR, Lønning PE (2011)
    Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel
    PLoS One, 6 (4), e19249
    DOI 10.1371/journal.pone.0019249, PubMed 21556366
  3. Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
    Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
    Acta Oncol, 50 (7), 1068-74
    DOI 10.3109/0284186X.2011.585998, PubMed 21745131
  4. Molloy TJ, Bosma AJ, Baumbusch LO, Synnestvedt M, Borgen E, Russnes HG, Schlichting E, van't Veer LJ, Naume B (2011)
    The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
    Breast Cancer Res, 13 (3), R61
    DOI 10.1186/bcr2898, PubMed 21672237
  5. Stafseth SK, Solms D, Bredal IS (2011)
    The characterisation of workloads and nursing staff allocation in intensive care units: a descriptive study using the Nursing Activities Score for the first time in Norway
    Intensive Crit Care Nurs, 27 (5), 290-4
    DOI 10.1016/j.iccn.2011.07.003, PubMed 21871805
  6. Steindal SA, Bredal IS, Sørbye LW, Lerdal A (2011)
    Pain control at the end of life: a comparative study of hospitalized cancer and noncancer patients
    Scand J Caring Sci, 25 (4), 771-9
    DOI 10.1111/j.1471-6712.2011.00892.x, PubMed 21564152
  7. Steindal SA, Sørbye LW, Bredal IS, Lerdal A (2011)
    Agreement in documentation of symptoms, clinical signs, and treatment at the end of life: a comparison of data retrieved from nurse interviews and electronic patient records using the Resident Assessment Instrument for Palliative Care
    J Clin Nurs, 21 (9-10), 1416-24
    DOI 10.1111/j.1365-2702.2011.03867.x, PubMed 22023535
  8. Suhrke P, Mæhlen J, Schlichting E, Jørgensen KJ, Gøtzsche PC, Zahl PH (2011)
    Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data
    BMJ, 343, d4692
    DOI 10.1136/bmj.d4692, PubMed 21914765
  9. Tveito S, Andersen K, Kåresen R, Fodstad Ø (2011)
    Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
    Breast Cancer Res, 13 (4), R75
    DOI 10.1186/bcr2922, PubMed 21816090
  10. Tøien K, Bredal IS, Skogstad L, Myhren H, Ekeberg O (2011)
    Health related quality of life in trauma patients. Data from a one-year follow up study compared with the general population
    Scand J Trauma Resusc Emerg Med, 19, 22
    DOI 10.1186/1757-7241-19-22, PubMed 21477280
  11. Tøien K, Skogstad L, Ekeberg Ø, Myhren H, Schou Bredal I (2011)
    Prevalence and predictors of return to work in hospitalised trauma patients during the first year after discharge: a prospective cohort study
    Injury, 43 (9), 1606-13
    DOI 10.1016/j.injury.2011.03.038, PubMed 21489524
  12. Vollan HK, Caldas C (2011)
    The breast cancer genome--a key for better oncology
    BMC Cancer, 11, 501
    DOI 10.1186/1471-2407-11-501, PubMed 22128823

Publications 2010

  1. Bredal IS (2010)
    The Norwegian version of the Mini-Mental Adjustment to Cancer Scale: factor structure and psychometric properties
    Psychooncology, 19 (2), 216-21
    DOI 10.1002/pon.1564, PubMed 19378351
  2. Bredal IS, Sandvik L, Karesen R, Ekeberg O (2010)
    Prognostic value of health-related quality-of-life parameters in early-stage breast cancer: an 8-year follow-up study
    Psychooncology, 20 (10), 1102-7
    DOI 10.1002/pon.1822, PubMed 20737644
  3. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B (2010)
    Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
    Breast Cancer Res Treat, 125 (3), 729-38
    DOI 10.1007/s10549-010-0911-2, PubMed 20449649
  4. Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB (2010)
    DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
    Mol Oncol, 5 (1), 77-92
    DOI 10.1016/j.molonc.2010.11.002, PubMed 21169070
  5. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
    Mol. Oncol., 4 (2), 169
  6. Rantala JK, Edgren H, Lehtinen L, Wolf M, Kleivi K, Vollan HK, Aaltola AR, Laasola P, Kilpinen S, Saviranta P, Iljin K, Kallioniemi O (2010)
    Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2
    Neoplasia, 12 (11), 877-88
    DOI 10.1593/neo.10548, PubMed 21082043
  7. Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
    Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
    Sci Transl Med, 2 (38), 38ra47
    DOI 10.1126/scitranslmed.3000611, PubMed 20592421
  8. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, Nilsen G, Lingjaerde OC, Børresen-Dale AL, Rødland E (2010)
    The importance of gene-centring microarray data
    Lancet Oncol, 11 (8), 719-20; author reply 720-1
    DOI 10.1016/S1470-2045(10)70174-1, PubMed 20688275
  9. Tøien K, Myhren H, Bredal IS, Skogstad L, Sandvik L, Ekeberg Ø (2010)
    Psychological distress after severe trauma: a prospective 1-year follow-up study of a trauma intensive care unit population
    J Trauma, 69 (6), 1552-9
    DOI 10.1097/TA.0b013e3181e125f3, PubMed 20664371

Publications 2009

  1. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
    Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
    Histol Histopathol, 24 (8), 1049-59
    DOI 10.14670/HH-24.1049, PubMed 19554512
  2. Emaus A, Veierød MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I (2009)
    Metabolic profile, physical activity, and mortality in breast cancer patients
    Breast Cancer Res Treat, 121 (3), 651-60
    DOI 10.1007/s10549-009-0603-y, PubMed 19882245
  3. Kalager M, Kåresen R, Wist E (2009)
    [Survival after breast cancer--differences between Norwegian counties]
    Tidsskr Nor Laegeforen, 129 (24), 2595-600
    DOI 10.4045/tidsskr.09.0024, PubMed 20029554
  4. Park D, Kåresen R, Naume B, Synnestvedt M, Beraki E, Sauer T (2009)
    The prognostic impact of occult nodal metastasis in early breast carcinoma
    Breast Cancer Res Treat, 118 (1), 57-66
    DOI 10.1007/s10549-009-0340-2, PubMed 19219629
  5. Sagen A, Kåresen R, Risberg MA (2009)
    Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up
    Acta Oncol, 48 (8), 1102-10
    DOI 10.3109/02841860903061683, PubMed 19863217
  6. Sagen A, Kåresen R, Sandvik L, Risberg MA (2009)
    Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study
    Acta Oncol, 48 (8), 1111-8
    DOI 10.3109/02841860903061691, PubMed 19863218
  7. Sagen A, Kåresen R, Skaane P, Risberg MA (2009)
    Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery
    Arch Phys Med Rehabil, 90 (5), 803-9
    DOI 10.1016/j.apmr.2008.11.016, PubMed 19406300

Publications 2008

  1. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
    Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
    Clin Cancer Res, 14 (8), 2341-50
    DOI 10.1158/1078-0432.CCR-07-4214, PubMed 18413823
  2. Schou I, Ekeberg O, Karesen R, Sorensen E (2008)
    Psychosocial intervention as a component of routine breast cancer care-who participates and does it help?
    Psychooncology, 17 (7), 716-20
    DOI 10.1002/pon.1264, PubMed 18033695

Publications 2007

  1. Chanock SJ, Burdett L, Yeager M, Llaca V, Langerød A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V, Perou CM, Børresen-Dale AL (2007)
    Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
    Breast Cancer Res, 9 (1), R5
    DOI 10.1186/bcr1637, PubMed 17224074
  2. Hval K, Thagaard KS, Schlichting E, Raeder J (2007)
    The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery
    Anesth Analg, 105 (2), 481-6
    DOI 10.1213/01.ane.0000267261.61444.69, PubMed 17646509
  3. Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS (2007)
    TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
    Breast Cancer Res, 9 (3), R30
    DOI 10.1186/bcr1675, PubMed 17504517
  4. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
    Mol Oncol, 1 (2), 160-71
    DOI 10.1016/j.molonc.2007.03.004, PubMed 19383292
  5. Park D, Kåresen R, Axcrona U, Noren T, Sauer T (2007)
    Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis
    APMIS, 115 (1), 52-65
    DOI 10.1111/j.1600-0463.2007.apm_524.x, PubMed 17223851
  6. Park D, Kåresen R, Noren T, Sauer T (2007)
    Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications
    Virchows Arch, 451 (1), 11-8
    DOI 10.1007/s00428-007-0435-2, PubMed 17554555

Publications 2006

  1. Schlichting E, Harr ME, Sauer T, Babovic A, Kåresen R (2006)
    [Sentinel lymph node biopsy in breast cancer]
    Tidsskr Nor Laegeforen, 126 (16), 2098-100
    PubMed 16932777

Publications 2005

  1. Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL (2005)
    Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications
    Clin Cancer Res, 11 (2 Pt 2), 878s-83s
    PubMed 15701881
  2. Lønning PE, Geisler J, Krag LE, Erikstein B, Bremnes Y, Hagen AI, Schlichting E, Lien EA, Ofjord ES, Paolini J, Polli A, Massimini G (2005)
    Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer
    J Clin Oncol, 23 (22), 5126-37
    DOI 10.1200/JCO.2005.07.097, PubMed 15983390
  3. Sagen A, Kåresen R, Risberg MA (2005)
    The reliability of a simplified water displacement instrument: a method for measuring arm volume
    Arch Phys Med Rehabil, 86 (1), 86-9
    DOI 10.1016/j.ampr.2003.12.042, PubMed 15640996
  4. Schou I, Ekeberg Ø, Ruland CM (2005)
    The mediating role of appraisal and coping in the relationship between optimism-pessimism and quality of life
    Psychooncology, 14 (9), 718-27
    DOI 10.1002/pon.896, PubMed 15669084
  5. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Sharma P, Zaka A, Arnes J, Sauer T, Akslen LA, Schlichting E, Børresen-Dale AL, Lönneborg A (2005)
    Early detection of breast cancer based on gene-expression patterns in peripheral blood cells
    Breast Cancer Res, 7 (5), R634-44
    DOI 10.1186/bcr1203, PubMed 16168108

Publications 2004

  1. Schou I, Ekeberg Ø, Ruland CM, Sandvik L, Kåresen R (2004)
    Pessimism as a predictor of emotional morbidity one year following breast cancer surgery
    Psychooncology, 13 (5), 309-20
    DOI 10.1002/pon.747, PubMed 15133772

Publications 2002

  1. Schou I, Ekeberg Ø, Ruland CM, Kåresen R (2002)
    Do women newly diagnosed with breast cancer and consulting surgeon assess decision-making equally?
    Breast, 11 (5), 434-41
    DOI 10.1054/brst.2002.0454, PubMed 14965708

Publications 1995

  1. OPSAHL E (1995)
    THE CROWNING OF ERIC-OF-POMMERANIA AND NORWAYS ROLE IN THE FORMATION OF THE KALMAR-UNION + COMMENTARY ON AN EARLIER ARTICLE BY HAUG,ELDBJORG
    Hist. Tidsskr., 74 (4), 473-491
  2. OPSAHL E (1995)
    NORWAY IN UNION IN THE 1300S, PTS 1 AND 2 - NORWEGIAN - BLOM,GA
    Hist. Tidsskr., 74 (4), 519-540
 
Page visits: 2629